Invitation to telephone conference in response to Dagens Industri’s article published on December 1
LUND, SWEDEN – Immunovia invites investors, analysts and the media to a telephone conference with CEO Patrik Dahlen tomorrow, Thursday, December 3, at CET 10:00 to address an article published on di.se on December 1: Experts skeptical to Immunovia’s bloodtest: “Would not count on it” (Experter skeptiska till Immunovias blodtest: ”Skulle inte satsa på detta”).The purpose of the telephone conference is to clarify how the company’s blood test for early detection of pancreatic cancer shall be used and the timeline for start of sales at the end of Q1 2021. Immunovia’s blood test, IMMray™